Activities per year
Activities
- 50 - 100 out of 202 results
Search results
-
Contributor: The Food Medic Educational Blog
Wallace, E. (Participant)
Aug 2019 → …Activity: Other activity types › Other
-
Media activity associated with ASA 2019 presentation
Appleton, S. (Participant)
18 Oct 2019Activity: Other activity types › Other
-
Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial. Held C, White HD, Stewart RAH, Davies R, Sampson S, Chiswell K, Silverstein A, Lopes RD, Heldestad U, Budaj A, Mahaffey KW, Wallentin L; STABILITY Investigators. Am Heart J. 2019 Feb;208:65-73. doi: 10.1016/j.ahj.2018.10.010. Epub 2018 Nov 7. PMID: 30572273 Clinical Trial.
Morton, E. (Other)
2019Activity: Other activity types › Other
-
Professor Christian Mueller discussing the RAPID TnT trial at the European Society of Cardiology Congress 2019
Morton, E. (Other)
2019Activity: Other activity types › Other
-
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS. Pagidipati NJ, Zheng Y, Green JB, McGuire DK, Mentz RJ, Shah S, Aschner P, Delibasi T, Rodbard HW, Westerhout CM, Holman RR, Peterson ED; TECOS Study Group. Am Heart J. 2020 Jan;219:47-57. doi: 10.1016/j.ahj.2019.09.016. Epub 2019 Oct 20. PMID: 31707324 Clinical Trial.
Morton, E. (Other)
2019Activity: Other activity types › Other
-
Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease. Stewart RAH, Held C, Krug-Gourley S, Waterworth D, Stebbins A, Chiswell K, Hagstrom E, Armstrong PW, Wallentin L, White H. J Am Heart Assoc. 2019 Apr 2;8(7):e010641. doi: 10.1161/JAHA.118.010641. PMID: 30897999 Clinical Trial.
Morton, E. (Participant)
2019Activity: Other activity types › Other
-
International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS. Bhatt AS, Luo N, Solomon N, Pagidipati NJ, Ambrosio G, Green JB, McGuire DK, Standl E, Cornel JH, Halvorsen S, Lopes RD, White HD, Holman RR, Peterson ED, Mentz RJ; TECOS Study Group. Am Heart J. 2019 Dec;218:57-65. doi: 10.1016/j.ahj.2019.08.016. Epub 2019 Aug 28. PMID: 31707329 Clinical Trial.
Morton, E. (Other)
2019Activity: Other activity types › Other
-
SAHMRI media publication - World-first trial reduces ED wait times and hospital admissions
Morton, E. (Other)
4 Sept 2019Activity: Other activity types › Other
-
Health Translation SA media publication - World-first trial reduces ED wait times and hospital admissions
Morton, E. (Other)
17 Sept 2019Activity: Other activity types › Other
-
Geriatric Advance Trainee - Project
Sinha, R. (Participant)
Feb 2019 → Nov 2019Activity: Other activity types › Other
-
Media associated with ASA 2019 presentation
Appleton, S. (Participant)
16 Oct 2019Activity: Other activity types › Other
-
Media associated with ASA 2019 presentation
Appleton, S. (Participant)
21 Oct 2019Activity: Other activity types › Other
-
European Society of Cardiology press release - RAPID-TnT trial
Morton, E. (Other)
3 Sept 2019Activity: Other activity types › Other
-
tctMD media publication - Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT
Morton, E. (Other)
3 Sept 2019Activity: Other activity types › Other
-
Professor Derek Chew presenting the RAPID TnT trial on the main stage at the European Society of Cardiology 2019
Morton, E. (Other)
2019Activity: Other activity types › Other
-
Facing your Fears
Venning, A. (Participant), Oswald, T. (Participant), Redpath, P. (Participant), Lawn, S. (Participant) & Morello, A. (Participant)
2018Activity: Other activity types › Other
-
How Anxiety affects Thinking
Venning, A. (Participant), Oswald, T. (Participant), Redpath, P. (Participant), Lawn, S. (Participant) & Morello, A. (Participant)
2018Activity: Other activity types › Other
-
NHMRC Research Excellence Award 2018
Craig, J. (Participant)
2018Activity: Other activity types › Other
-
Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Davis TME, Mulder H, Lokhnygina Y, Aschner P, Chuang LM, Raffo Grado CA, Standl E, Peterson ED, Holman RR; TECOS Study Group. Diabetes Obes Metab. 2018 Jun;20(6):1427-1434. doi: 10.1111/dom.13242. Epub 2018 Feb 28. PMID: 29405540 Clinical Trial.
Morton, E. (Other)
2018Activity: Other activity types › Other
-
Taking Command of Anxiety
Venning, A. (Participant), Oswald, T. (Participant), Redpath, P. (Participant), Lawn, S. (Participant) & Morello, A. (Participant)
2018Activity: Other activity types › Other
-
How Pain affects my Thinking
Venning, A. (Participant), Oswald, T. (Participant), Redpath, P. (Participant), Lawn, S. (Participant) & Morello, A. (Participant)
2018Activity: Other activity types › Other
-
Pain Medication
Venning, A. (Participant), Oswald, T. (Participant), Redpath, P. (Participant), Lawn, S. (Participant) & Morello, A. (Participant)
2018Activity: Other activity types › Other
-
Primary Prevention. In Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Cancer Council Australia, 2018.
Macrae, F. (Other), Clarke, J. (Other), Emery, J. (Other), Jenkins, M. (Other), Lockett, T. (Other), McNeil, J. (Other), Spigelman, A. (Other), Patcher, N. (Other), Win, A. K. (Other), Woods, R. (Other), Young AM FTSE FAHMS AGAF, G. P. (Other) & Zalcberg, J. R. (Other)
2018Activity: Other activity types › Other
-
Public Speaker: SAHMRI public and school tours
Downes, C. E. (Participant)
Feb 2018 → May 2022Activity: Other activity types › Other
-
Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide. Gut, 2018 Apr;67(4):679-687. doi: 10.1136/gutjnl-2016-313311.
de Klerk, C. M. (Other), Gupta, S. (Other), Dekker, E. (Other), Essink-Bot, M. L. (Other), Expert Working Group ‘Coalition to reduce inequities in colorectal cancer screening’ of the World Endoscopy Organization (Other) & Young AM FTSE FAHMS AGAF, G. P. (Other)
2018Activity: Other activity types › Other
-
-
Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial. Tricoci P, Neely M, Whitley MJ, Edelstein LC, Simon LM, Shaw C, Fortina P, Moliterno DJ, Armstrong PW, Aylward P, White H, Van de Werf F, Jennings LK, Wallentin L, Held C, Harrington RA, Mahaffey KW, Bray PF. Blood Cells Mol Dis. 2018 Sep;72:37-43. doi: 10.1016/j.bcmd.2018.07.004. Epub 2018 Jul 21. PMID: 30055940. Clinical Trial.
Morton, E. (Other)
2018Activity: Other activity types › Other
-
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial. Ungar L, Clare RM, Rodriguez F, Kolls BJ, Armstrong PW, Aylward P, Held C, Moliterno DJ, Strony J, Van de Werf F, Wallentin L, White HD, Tricoci P, Harrington RA, Mahaffey KW, Melloni C. J Am Heart Assoc. 2018 Dec 18;7(24):e009609. doi: 10.1161/JAHA.118.009609. PMID: 30526198
Morton, E. (Other)
2018Activity: Other activity types › Other
-
NHMRC Grant Management Solution Working Group
Yazbek, R. (Participant)
29 Nov 2017 → 17 May 2021Activity: Other activity types › Other
-
Re-Thinking Chronic Pain
Redpath, P. (Participant), Venning, A. (Participant), Oswald, T. (Participant) & Wall, C. (Participant)
30 Jan 2017Activity: Other activity types › Other
-
Physical Activity and Mortality in Patients With Stable Coronary Heart Disease. Stewart RAH, Held C, Hadziosmanovic N, Armstrong PW, Cannon CP, Granger CB, Hagström E, Hochman JS, Koenig W, Lonn E, Nicolau JC, Steg PG, Vedin O, Wallentin L, White HD; STABILITY Investigators. J Am Coll Cardiol. 2017 Oct 3;70(14):1689-1700. doi: 10.1016/j.jacc.2017.08.017. PMID: 28958324 Clinical Trial.
Morton, E. (Other)
2017Activity: Other activity types › Other
-
Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Held C, White HD, Stewart RAH, Budaj A, Cannon CP, Hochman JS, Koenig W, Siegbahn A, Steg PG, Soffer J, Weaver WD, Östlund O, Wallentin L; STABILITY Investigators. J Am Heart Assoc. 2017 Oct 24;6(10):e005077. doi: 10.1161/JAHA.116.005077. PMID: 29066452. Clinical Trial.
Morton, E. (Other)
2017Activity: Other activity types › Other
-
Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib. Yeo A, Li L, Warren L, Aponte J, Fraser D, King K, Johansson K, Barnes A, MacPhee C, Davies R, Chissoe S, Tarka E, O'Donoghue ML, White HD, Wallentin L, Waterworth D. PLoS One. 2017 Jul 28;12(7):e0182115. doi: 10.1371/journal.pone.0182115. eCollection 2017. PMID: 28753643.
Morton, E. (Other)
2017Activity: Other activity types › Other
-
Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Guimarães PO, Granger CB, Stebbins A, Chiswell K, Held C, Hochman JS, Krug-Gourley S, Lonn E, Lopes RD, Stewart RAH, Vinereanu D, Wallentin L, White HD, Hagström E, Danchin N. J Am Heart Assoc. 2017 Sep 14;6(9):e006695. doi: 10.1161/JAHA.117.006695. PMID: 28912210. Clinical Trial.
Morton, E. (Other)
2017Activity: Other activity types › Other
-
Anxiety group program
Venning, A. (Participant), Redpath, P. (Participant), Oswald, T. (Participant), Morello, A. (Participant) & Lawn, S. (Participant)
2017Activity: Other activity types › Other
-
Pain Group program
Redpath, P. (Participant), Venning, A. (Participant), Oswald, T. (Participant), Morello, A. (Participant) & Lawn, S. (Participant)
2017Activity: Other activity types › Other
-
Perinatal Mental health: Bouncing Back after Baby
Redpath, P. (Participant), Venning, A. (Participant), Glover, F. (Participant) & Oswald, T. K. (Participant)
30 Jan 2017Activity: Other activity types › Other
-
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial. Sharma A, Green JB, Dunning A, Lokhnygina Y, Al-Khatib SM, Lopes RD, Buse JB, Lachin JM, Van de Werf F, Armstrong PW, Kaufman KD, Standl E, Chan JCN, Distiller LA, Scott R, Peterson ED, Holman RR; TECOS Study Group. Diabetes Care. 2017 Dec;40(12):1763-1770. doi: 10.2337/dc17-1091. Epub 2017 Oct 6. PMID: 28986504
Morton, E. (Other)
2017Activity: Other activity types › Other
-
Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease. Gryka RJ, Buckley LF, Anderson SM. Drugs R D. 2017 Mar;17(1):65-72. doi: 10.1007/s40268-016-0158-4. PMID: 28063023. Review.
Morton, E. (Other)
2017Activity: Other activity types › Other
-
Student Volunteer: AusBiotech conference 2017
Downes, C. E. (Participant)
Oct 2017Activity: Other activity types › Other
-
Post Traumatic Stress Disorder: Processing the Past, Redefining the Future
Venning, A. (Participant), Redpath, P. (Participant) & Oswald, T. K. (Participant)
30 Jan 2017Activity: Other activity types › Other
-
Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study. Andrews J, Janssan A, Nguyen T, Pisaniello AD, Scherer DJ, Kastelein JJ, Merkely B, Nissen SE, Ray K, Schwartz GG, Worthley SG, Keyserling C, Dasseux JL, Butters J, Girardi J, Miller R, Nicholls SJ. Cardiovasc Diagn Ther. 2017 Feb;7(1):45-51. doi: 10.21037/cdt.2017.01.01. PMID: 28164012; PMCID: PMC5253449. H-index
Morton, E. (Other)
2017Activity: Other activity types › Other
-
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial. Josse RG, Majumdar SR, Zheng Y, Adler A, Bethel MA, Buse JB, Green JB, Kaufman KD, Rodbard HW, Tankova T, Westerhout CM, Peterson ED, Holman RR, Armstrong PW; TECOS Study Group. Diabetes Obes Metab. 2017 Jan;19(1):78-86. doi: 10.1111/dom.12786. Epub 2016 Oct 6. PMID: 27607571 Clinical Trial.
Morton, E. (Other)
2017Activity: Other activity types › Other
-
Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS. Engel SS, Suryawanshi S, Stevens SR, Josse RG, Cornel JH, Jakuboniene N, Riefflin A, Tankova T, Wainstein J, Peterson ED, Holman RR; TECOS Study Group. Diabetes Obes Metab. 2017 Nov;19(11):1587-1593. doi: 10.1111/dom.12983. Epub 2017 Jul 7. PMID: 28432745 Clinical Trial.
Morton, E. (Other)
2017Activity: Other activity types › Other
-
Fundraising Volunteer: Cancer Council Relay for Life
Downes, C. E. (Participant)
Oct 2017Activity: Other activity types › Other
-
Tuning into Kids Emotional Growth Psychological Clinic Course
Matthews, S. (Participant)
24 Jun 2016Activity: Other activity types › Other
-
Chloro-chek Chloridometer Key Operator Training Course
Matthews, S. (Participant)
2 Nov 2016Activity: Other activity types › Other
-
Pancreatic Safety of Sitagliptin in the TECOS Study. Buse JB, Bethel MA, Green JB, Stevens SR, Lokhnygina Y, Aschner P, Grado CR, Tankova T, Wainstein J, Josse R, Lachin JM, Engel SS, Patel K, Peterson ED, Holman RR; TECOS Study Group. Diabetes Care. 2017 Feb;40(2):164-170. doi: 10.2337/dc15-2780. Epub 2016 Sep 14. PMID: 27630212. Clinical Trial.
Morton, E. (Other)
2016Activity: Other activity types › Other
-
Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial. Harskamp RE, Clare RM, Ambrosio G, Held C, Lokhnygina Y, Moliterno DJ, White HD, Aylward PE, Armstrong PW, Mahaffey KW, Harrington RA, Van de Werf F, Wallentin L, Strony J, Tricoci P. Eur Heart J Acute Cardiovasc Care. 2017 Mar;6(2):155-163. doi: 10.1177/2048872616633880. Epub 2016 Sep 20. PMID: 26895973 Clinical Trial.
Morton, E. (Other)
2016Activity: Other activity types › Other
-
Vorapaxar monotherapy for secondary stroke prevention: A call for randomized trial. Serebruany VL, Kim MH, Hanley DF. Int J Stroke. 2016 Aug;11(6):614-7. doi: 10.1177/1747493016632253. Epub 2016 Feb 9. PMID: 26860124 Review.
Morton, E. (Other)
2016Activity: Other activity types › Other